L3MBTL1 regulates ALS/FTD-associated proteotoxicity and quality control

Area of Science:

• Neurobiology
• Molecular Biology
• Genetics

Background:

• Misfolded protein accumulation and impaired protein quality control are hallmarks of neurodegenerative diseases like ALS and FTD.
• Identifying key regulators of protein quality control is crucial for understanding disease mechanisms.

Purpose of the Study:

• To identify novel regulators of protein quality control involved in neurodegeneration.
• To elucidate the role of Lethal(3)malignant brain tumor-like protein 1 (L3MBTL1) in protein quality control and neuroprotection.

Main Methods:

• Proteotoxicity assays using mutant proteins (SOD1, C9orf72 repeats).
• Analysis of p53-dependent protein degradation pathways.
• Western blotting and immunohistochemistry in cell and animal models.
• Comparative analysis across species (C. elegans to mammals).

Main Results:

• L3MBTL1 was identified as a key regulator of protein quality control.
• Loss of L3MBTL1 conferred protection against proteotoxicity from mutant SOD1 and C9orf72 proteins.
• L3MBTL1 regulates p53-dependent degradation of misfolded proteins.
• SET domain-containing protein 8, an L3MBTL1-associated protein, also impacts protein clearance.
• L3MBTL1 and SETDB1 are upregulated in ALS/FTD models and patients.
• L3MBTL1's function in protein quality control is evolutionarily conserved.

Conclusions:

• A novel protein quality control pathway involving L3MBTL1 and SETDB1 is revealed.
• This pathway is critical for cellular stress response and implicated in proteotoxicity-driven neurodegenerative diseases.
• Targeting this pathway may offer therapeutic strategies for ALS and FTD.